Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 5.

Journal Article

Albrecht, K., Englbrecht, M., Baerwald, C., Feist, E., Fleck, M., Gromnica-Ihle, E., Koehler, L., Koetter, I., Kneitz, C., Krueger, K., Kuipers, J., Nuesslein, H., Rubbert-Roth, A., Wollenhaupt, J., Schneider, M., Manger, B., Mueller-Ladner, U. and Tarner, I. H. (2015). National and Multinational Evidence-based Recommendations for Medical Pain Management in Inflammatory Joint Disease: Systematic Literature Research and Expert Opinion in the 3e Initiative. Aktuelle Rheumatol., 40 (1). S. 67 - 77. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-9940

Behrens, F., Rossmanith, T., Kohm, M., Alten, R., Aringer, M., Backhaus, M., Baerwald, C., Burmester, G., Feist, E., Kellner, H., Krger, K., Muller-Ladner, U., Rubbert-Roth, A., Tony, H. -P., Wassenberg, S. and Burkhardt, H. (2016). RITUXIMAB IN COMBINATION WITH LEFLUNOMIDE: RESULTS FROM A MULTICENTER RANDOMIZED PLACEBO CONTROLLED INVESTIGATOR INITIATED CLINICAL TRIAL IN ACTIVE RHEUMATOID ARTHRITIS (AMARA-STUDY). Ann. Rheum. Dis., 75. S. 502 - 503. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060

Henes, J., Saur, S., Kofler, D. M., Kedor, C., Meisner, C., Krusche, M., Koetter, I., Xenitidis, T., Schulze-Koops, H. and Feist, E. (2022). TOCILIZUMAB SIGNIFICANTLY REDUCES SERUM AMYLOID A IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER - DATA FROM THE PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND TOFFIFE STUDY. Ann. Rheum. Dis., 81. S. 30 - 32. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060

Koehm, M., Rossmanith, T., Dauth, S., Alten, R., Aringer, M., Backhaus, M., Burmester, G., Feist, E., Kellner, H., Krueger, K., Mueller-Ladner, U., Rubbert-Roth, A., Tony, H-P., Wassenberg, S., Burkhardt, H. and Behrens, F. (2017). IMPACT OF RITUXIMAB IN COMBINATION WITH LEFLUNOMIDE AND RITUXIMAB RETREATMENT WITH TWO DIFFERENT DOSAGES ON PATIENT-REPORTED OUTCOMES: RESULTS FROM A MULTICENTER RANDOMIZED PLACEBO CONTROLLED INVESTIGATOR INITIATED CLINICAL TRIAL IN ACTIVE RHEUMATOID ARTHRITIS (AMARA-STUDY). Ann. Rheum. Dis., 76. S. 565 - 566. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060

Rech, J., Kleyer, A., Ostergaard, M., Hagen, M., Valor, L., Tascilar, K., Kronke, G., Schonau, V., Kleinert, S., Baraliakos, X., Braun, J., Fleck, M., Rubbert-Roth, A., Behrens, F., Feuchtenberger, M., Zaenker, M., Kofler, D. M., Voll, R., Glaser, C., Hueber, A., Feist, E., Burmester, G. R., Karberg, K., Strunk, J., Canete, J. D. D., Senolt, L., Naredo, E. and Schett, G. (2022). ABATACEPT DELAYS THE DEVELOPMENT OF RA-CLINICAL RESULTS AFTER 18 MONTHS FROM THE RANDOMIZED, PLACEBO-CONTROLLED ARIAA STUDY IN RA-AT RISK PATIENTS. Ann. Rheum. Dis., 81. S. 526 - 528. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060

This list was generated on Wed May 22 22:59:13 2024 CEST.